2-[8-[(E)-3-(2-methoxyphenyl)prop-2-enyl]-2,4-dioxo-1-(2-phenylethyl)-1,3,8-triazaspiro[4.5]decan-3-yl]acetamide

C27H32N4O4 — CID 26142233

IUPAC2-[8-[(E)-3-(2-methoxyphenyl)prop-2-enyl]-2,4-dioxo-1-(2-phenylethyl)-1,3,8-triazaspiro[4.5]decan-3-yl]acetamide
SMILESCOc1ccccc1/C=C/CN1CCC2(CC1)C(=O)N(CC(N)=O)C(=O)N2CCc1ccccc1
InChIInChI=1S/C27H32N4O4/c1-35-23-12-6-5-10-22(23)11-7-16-29-18-14-27(15-19-29)25(33)30(20-24(28)32)26(34)31(27)17-13-21-8-3-2-4-9-21/h2-12H,13-20H2,1H3,(H2,28,32)/b11-7+
InChIKeyOMFCMUIDIHYEQT-YRNVUSSQSA-N
MW476.58 g/mol
LogP2.54
Rot. Bonds9

About 2-[8-[(E)-3-(2-methoxyphenyl)prop-2-enyl]-2,4-dioxo-1-(2-phenylethyl)-1,3,8-triazaspiro[4.5]decan-3-yl]acetamide

2-[8-[(E)-3-(2-methoxyphenyl)prop-2-enyl]-2,4-dioxo-1-(2-phenylethyl)-1,3,8-triazaspiro[4.5]decan-3-yl]acetamide (PubChem CID 26142233) has the molecular formula C27H32N4O4 and a molecular weight of 476.58 g/mol. Its IUPAC name is 2-[8-[(E)-3-(2-methoxyphenyl)prop-2-enyl]-2,4-dioxo-1-(2-phenylethyl)-1,3,8-triazaspiro[4.5]decan-3-yl]acetamide.

Molecular Properties

Compound Name2-[8-[(E)-3-(2-methoxyphenyl)prop-2-enyl]-2,4-dioxo-1-(2-phenylethyl)-1,3,8-triazaspiro[4.5]decan-3-yl]acetamide
PubChem CID26142233
Molecular FormulaC27H32N4O4
Molecular Weight476.58 g/mol
Exact Mass476.24
IUPAC Name2-[8-[(E)-3-(2-methoxyphenyl)prop-2-enyl]-2,4-dioxo-1-(2-phenylethyl)-1,3,8-triazaspiro[4.5]decan-3-yl]acetamide
SMILESCOc1ccccc1/C=C/CN1CCC2(CC1)C(=O)N(CC(N)=O)C(=O)N2CCc1ccccc1
InChIInChI=1S/C27H32N4O4/c1-35-23-12-6-5-10-22(23)11-7-16-29-18-14-27(15-19-29)25(33)30(20-24(28)32)26(34)31(27)17-13-21-8-3-2-4-9-21/h2-12H,13-20H2,1H3,(H2,28,32)/b11-7+
InChIKeyOMFCMUIDIHYEQT-YRNVUSSQSA-N
XLogP2.54
TPSA96.18 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds9
Heavy Atoms35
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500476.58
LogP ≤ 52.54
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydantoin', 'substructure': 'N/A'}

Analyze 2-[8-[(E)-3-(2-methoxyphenyl)prop-2-enyl]-2,4-dioxo-1-(2-phenylethyl)-1,3,8-triazaspiro[4.5]decan-3-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[8-[(E)-3-(2-methoxyphenyl)prop-2-enyl]-2,4-dioxo-1-(2-phenylethyl)-1,3,8-triazaspiro[4.5]decan-3-yl]acetamide?
The IUPAC name of 2-[8-[(E)-3-(2-methoxyphenyl)prop-2-enyl]-2,4-dioxo-1-(2-phenylethyl)-1,3,8-triazaspiro[4.5]decan-3-yl]acetamide (CID 26142233) is 2-[8-[(E)-3-(2-methoxyphenyl)prop-2-enyl]-2,4-dioxo-1-(2-phenylethyl)-1,3,8-triazaspiro[4.5]decan-3-yl]acetamide.
What is the SMILES notation for 2-[8-[(E)-3-(2-methoxyphenyl)prop-2-enyl]-2,4-dioxo-1-(2-phenylethyl)-1,3,8-triazaspiro[4.5]decan-3-yl]acetamide?
The canonical SMILES for 2-[8-[(E)-3-(2-methoxyphenyl)prop-2-enyl]-2,4-dioxo-1-(2-phenylethyl)-1,3,8-triazaspiro[4.5]decan-3-yl]acetamide is COc1ccccc1/C=C/CN1CCC2(CC1)C(=O)N(CC(N)=O)C(=O)N2CCc1ccccc1.
What is the InChIKey of 2-[8-[(E)-3-(2-methoxyphenyl)prop-2-enyl]-2,4-dioxo-1-(2-phenylethyl)-1,3,8-triazaspiro[4.5]decan-3-yl]acetamide?
The InChIKey is OMFCMUIDIHYEQT-YRNVUSSQSA-N. The full InChI is InChI=1S/C27H32N4O4/c1-35-23-12-6-5-10-22(23)11-7-16-29-18-14-27(15-19-29)25(33)30(20-24(28)32)26(34)31(27)17-13-21-8-3-2-4-9-21/h2-12H,13-20H2,1H3,(H2,28,32)/b11-7+.
What are the key properties of 2-[8-[(E)-3-(2-methoxyphenyl)prop-2-enyl]-2,4-dioxo-1-(2-phenylethyl)-1,3,8-triazaspiro[4.5]decan-3-yl]acetamide?
2-[8-[(E)-3-(2-methoxyphenyl)prop-2-enyl]-2,4-dioxo-1-(2-phenylethyl)-1,3,8-triazaspiro[4.5]decan-3-yl]acetamide has a molecular weight of 476.58 g/mol, XLogP of 2.54, 9 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[8-[(E)-3-(2-methoxyphenyl)prop-2-enyl]-2,4-dioxo-1-(2-phenylethyl)-1,3,8-triazaspiro[4.5]decan-3-yl]acetamide is sourced from PubChem (CID 26142233), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).